ReviewHepatic medicine : evidence and research2015
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
Sujit V Janardhan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it